Brief: Cancer Genetics Files For Non-Timely 10-Q With U.S. SEC

Vyant Bio

14/11/2019 23:05

Nov 14 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS - FILES FOR NON-TIMELY 10-Q WITH U.S. SEC
    * CANCER GENETICS - DELAY IS DUE PRIMARILY TO RECENT ASSET
SALES
OF CLINICAL BUSINESS & BIOPHARMA BUSINESS
    * CANCER GENETICS - DUE TO BIOPHARMA BUSINESS SALE, CO LOST
NUMEROUS EMPLOYEES
    * CANCER GENETICS - PLANS TO FILE FORM 10-Q FOR QUARTER
ENDED SEPT
30, 2019 WITH SEC AS SOON AS PRACTICABLE

Source: (https://bit.ly/2ObZNJ7)
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))